HHSC To Remove Oxbryta Products From All Formularies As Of Oct. 10, 2024 HHSC will remove Oxbryta products from the Medicaid formulary on Oct. 10, 2024. Other News: Members Sought for the Drug Utilization Review Board (Applications due Nov. 1) 2024–25 RSV Season and Synagis Prior Authorization Begins for State Health Regions Columbus Day Holiday to Delay Pharmacy Payments Reminder: VDP Changed PDL Status for "Glucocorticoids, Inhaled" Drug Class on Dec. 15, 2023 Pharmacy Education Reminders: Pharmacy Education Information and Opportunities Pharmacy Contact Information Must Be Current in PEMS

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to ooseims.archieves@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202